Demant released a trading update on Oct. 9, 2026, citing strong US sales of its newly launched Oticon Zeal product, and announced a DKK 3 billion share buyback program through 2027. Shares rose 6% on the day.
Demant’s strong product pipeline, led by the global rollout of Oticon Zeal in 2026, will likely result in above-market growth in the next few years.
Demant has underperformed Sonova over the last two years in hearing aids. Sonova was the first to introduce real-time AI implementation, taking share from Demant.
|
Metric
|
DEMANT
|
SOON
|
|---|---|---|
Price/Earnings (Normalized) | 29.88 | 28.32 |
Price/Book Value | 6.86 | 6.45 |
Price/Sales | 3.13 | 4.69 |
Price/Cash Flow | 18.03 | 21.91 |
|
Metric
|
DEMANT
|
SOON
|
|---|---|---|
Quick Ratio | 0.54 | 1.17 |
Current Ratio | 0.82 | 1.75 |
Interest Coverage | 6.70 | 23.14 |
|
Metric
|
DEMANT
|
SOON
|
|---|---|---|
Return on Assets (Normalized) | 6.76% | 11.07% |
Return on Equity (Normalized) | 24.80% | 24.50% |
Return on Invested Capital (Normalized) | 9.75% | 16.97% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|fYd<kB | LOCK|prVr? | $184B | |||
| Medtronic PLC
MDT
| LOCK|X!B^bR | LOCK|kz@j? | $123B | |||
| Stryker Corp
SYK
| LOCK|GDB?%cC& | LOCK|&!$ | $111B | |||
| Boston Scientific Corp
BSX
| LOCK|$k>sFd< | LOCK|?gTH | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|qccQCvP | LOCK|l!?y | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$$ZstRf | LOCK|$M | $35B | |||
| DexCom Inc
DXCM
| LOCK|@%!TDsk^ | LOCK|%#V! | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|X!& | LOCK|?N | $26B | |||
| Steris PLC
STE
| LOCK|lrtKtz% | LOCK|sl&Y | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^vt^F>& | LOCK|n$! | $18B |
United States